REFERENCES
- Neglia JP, Friedman DL, Yasui Y, et al. Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. J Natl Cancer Inst. 2001; 93: 618–629
- Zeimet AG, Thaler J, Abfalter E, Marth C, Dapunt O. Secondary leukaemias after etoposide. Lancet 1992; 340: 379–380
- Hunger SP, Sklar J, Link MP. Acute lymphoblastic leukemia occurring as a second malignant neoplasm in childhood: report of three cases and review of the literature. J Clin Oncol. 1992; 10: 156–163
- Davies SM. Therapy-related leukemia associated with alkylating agents. Med Pediatr Oncol. 2001; 36: 536–540
- Felix CA. Leukemias related to treatment with DNA topoisomerase II inhibitors. Med Pediatr Oncol. 2001; 36: 525–535
- Sandoval C, Pui CH, Bowman LC, et al. Secondary acute myeloid leukemia in children previously treated with alkylating agents, intercalating topoisomerase II inhibitors, and irradiation. J Clin Oncol. 1993; 11: 1039–1045
- Hornick JL, Fletcher CD. PEComa: what do we know so far?. Histopathology 2006; 48: 75–82
- Jeon IS, Lee SM. Multimodal treatment using surgery, radiotherapy, and chemotherapy in a patient with a perivascular epithelioid cell tumor of the uterus. J Pediatr Hematol Oncol. 2005; 27: 681–684
- Walter AW, Shearer PD, Pappo AS, et al. A pilot study of vincristine, ifosfamide, and doxorubicin in the treatment of pediatric non-rhabdomyosarcoma soft tissue sarcomas. Med Pediatr Oncol. 1998; 30: 210–216
- Bhatia S, Sklar C. Second cancers in survivors of childhood cancer. Nat Rev Cancer 2002; 2: 124–132
- Rich DC, Corpron CA, Smith MB, Black CT, Lally KP, Andrassy RJ. Second malignant neoplasms in children after treatment of soft tissue sarcoma. J Pediatr Surg. 1997; 32: 369–372
- Caglar K, Varan A, Akyuz C, et al. Second neoplasms in pediatric patients treated for cancer: a center's 30-year experience. Pediatr Hematol Oncol. 2006; 28: 374–378
- Scaradavou A, Heller G, Sklar CA, Ren L, Ghavimi F. Second malignant neoplasms in long-term survivors of childhood rhabdomyosarcoma. Cancer 1995; 76: 1860–1867
- Smith MA, Rubinstein L, Anderson JR, et al. Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins. J Clin Oncol. 1999; 17: 569–577
- Megonigal MD, Cheung NK, Rappaport EF, et al. Detection of leukemia-associated MLL-GAS7 translocation early during chemotherapy with DNA topoisomerase II inhibitors. Proc Natl Acad Sci U S A 2000; 97: 2814–2819